DISGRACE: Advanced Oncotherapy – Beyond A Joke As AIM Continues To Break Its Own Rules
Aim-listed Advanced Oncotherapy (AVO) should have been sent for a one-way trip to the AIM Executioner at the end of December. Yet first in January, then in February, and now at the beginning of April, AIM has broken its own rules in not enforcing that outcome. What is the point of rules?


